Franklin Resources
LYEL icon

Franklin Resources’s Lyell Immunopharma LYEL Stock Holding History

Franklin Resources’s Portfolio LYEL Stock Details LYEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-4,933
Closed -$143K – 2981
2024
Q2 		$143K Buy
4,933
+772
+19% +$36.8K ﹤0.01% 2624
2024
Q1 		$186K Hold
4,161
– – ﹤0.01% 2612
2023
Q4 		$161K Hold
4,161
– – ﹤0.01% 2391
2023
Q3 		$122K Hold
4,161
– – ﹤0.01% 2432
2023
Q2 		$265K Buy
+4,161
New +$230K ﹤0.01% 2265

Other funds holding LYEL

MM
MWG Management Road Town, Tortola, British Virgin Islands $81.3M AUM 2.28% 1-Year Est. Return
OPL
Orland Properties Ltd Road Town, Tortola, British Virgin Islands $202M AUM 2.79% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $290M AUM 143.88% 1-Year Est. Return
WA
WuXi AppTec Shanghai, China $19M AUM 20.22% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
OrbiMed
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Alphabet Inc
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources's LYEL Position: Q3 2024 in Review

Franklin Resources sold out of Lyell Immunopharma (LYEL) in Q3 2024, closing a stake of 4,933 shares — an estimated $143K sold.

Franklin Resources first reported a position in LYEL in Q2 2023 and held it in 5 quarters. The position peaked at $265K in Q2 2023. 117 funds tracked by Wall St. Rank hold LYEL as of Q3 2024.

  • Franklin Resources reported no remaining Lyell Immunopharma position as of Q3 2024 after selling out during the quarter.
  • Franklin Resources sold 4,933 Lyell Immunopharma shares in Q3 2024, an estimated $143K.
  • Franklin Resources first reported a position in Lyell Immunopharma in Q2 2023 and held it in 5 quarters.
  • Franklin Resources's Lyell Immunopharma position peaked at $265K in Q2 2023.
  • 117 funds tracked by Wall St. Rank held Lyell Immunopharma as of Q3 2024.

Based on Franklin Resources's 13F filing for Q3 2024, filed 12 Nov 2024.